Yahoo Web Search

Search results

    • Vanda Pharma Rejects Future Pak's Sweetened Takeover Bid

      Market Watch· 19 hours ago

      The board of Vanda Pharmaceuticals has rejected Future Pak's sweetened proposal for a takeover at $7.25 to $7.75 a share, saying the offer is still too low. The biopharmaceutical company's board ...